A unique tolerance inducing therapy for the treatment of the Orphan disease Myasthenia Gravis (MG)
Will support further development of abatement strategies within europe by providing an improved scientific basis for the quantification of source-receptor relationships for photo-oxidants and acidifying substances.
There are two main challenges: 1. To become sustainable by reducing resource consumption, managing transport and utility networks in a sustainable way, reducing environmental and man-made impacts, improving safety and security and protecting cultural heritage; 2. To become a demand-driven sector.